Patent details
EP3378535 Title: HUMANIZED ANTIBODIES THAT RECOGNIZE ALPHA-SYNUCLEIN
Basic Information
- Publication number:
- EP3378535
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP181554411
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- HUMANIZED ANTIBODIES THAT RECOGNIZE ALPHA-SYNUCLEIN
- French Title of Invention:
- ANTICORPS HUMANISÉS RECONNAISSANT L'ALPHA-SYNUCLÉINE
- German Title of Invention:
- ALPHA-SYNUKLEIN ERKENNENDE HUMANISIERTE ANTIKÖRPER
- SPC Number:
Dates
- Filing date:
- 26/10/2012
- Grant date:
- 04/01/2023
- EP Publication Date:
- 26/09/2018
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 04/01/2023
- EP B1 Publication Date:
- 04/01/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 26/10/2032
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 28/12/2022
- Name:
- Prothena Biosciences Limited
- Address:
- 77 Sir John Rogerson's Quay, Block C Grand Canal Docklands, Dublin 2, D02 VK60, Ireland (IE)
Agent
- Name:
- NOVAGRAAF BREVETS
- From:
- 12/01/2023
- Address:
- BÂTIMENT O2, 2 RUE SARAH BERNHARDT CS90017, 92665, ASNIÈRES-SUR-SEINE cedex, France (FR)
- To:
Inventor
1
- Name:
- SALDANHA, Jose
- Address:
- United Kingdom (GB)
2
- Name:
- NIJJAR, Tarlochan
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201161553131 P
- Priority Date:
- 28/10/2011
- Priority Country:
- United States (US)
2
- Priority Number:
- 201261711208 P
- Priority Date:
- 08/10/2012
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61P 25/16; A61K 39/00; C07K 16/18;
Publication
European Patent Bulletin
- Issue number:
- 202301
- Publication date:
- 04/01/2023
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- 31/10/2025
- Annual Fee Number:
- 14
- Annual Fee Amount:
- 198 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 25/09/2024
- Last Annual Fee Paid Number:
- 13
- Last Annual Fee Paid Amount:
- 180 Euro
- Payer:
- ACUMASS SARL
| Filing date | Document type | Number of pages |
|---|---|---|
| 13/01/2023 | Outgoing Correspondence | 1 |
| 11/01/2023 | Power Of Attorney | 1 |